201 results on '"Corcoran, Timothy E."'
Search Results
2. Editorial: Mechanobiology of biofilms and associated host -pathogen interactions
3. New path for understanding mucociliary clearance
4. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study
5. Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
6. Flow regime transitions and effects on solute transport in surfactant-driven Marangoni flows
7. A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia
8. Surfactant-induced Marangoni transport of lipids and therapeutics within the lung
9. Evolution and disappearance of solvent drops on miscible polymer subphases
10. A Dynamic Model of Cystic Fibrosis Airway Epithelium Electrophysiology
11. Transport of a partially wetted particle at the liquid/vapor interface under the influence of an externally imposed surfactant generated Marangoni stress
12. Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis
13. Enabling Marangoni flow at air-liquid interfaces through deposition of aerosolized lipid dispersions
14. Preclinical Studies of the Nebulized Delivery of Liposomal Amphotericin B
15. Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic response
16. Pilot study of nuclear scintigraphy to assess cough clearance in DMD
17. CFD Study of Dry Pulmonary Surfactant Aerosols Deposition in Upper 17 Generations of Human Respiratory Tract
18. Physiologically-Based Model of Fluid Absorption and Mucociliary Clearance in Cystic Fibrosis
19. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis
20. Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study
21. Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation
22. Effect of a Surfactant Additive on Drug Transport and Distribution Uniformity After Aerosol Delivery to Ex Vivo Lungs
23. Liquid hyper-absorption as a cause of increased DTPA clearance in the cystic fibrosis airway
24. Mucociliary Clearance Scans Show Infants Undergoing Congenital Cardiac Surgery Have Poor Airway Clearance Function
25. Measurements of deposited aerosol dose in infants and small children
26. Effect of a Surfactant Additive on Drug Transport and Distribution Uniformity After Aerosol Delivery to Ex Vivo Lungs.
27. Aerosol and Droplet Risk of Common Otolaryngology Clinic Procedures
28. A randomized trial of inhaled cyclosporine in lung-transplant recipients
29. Droplet and Aerosol Generation With Mastoidectomy During the COVID-19 Pandemic: Assessment of Baseline Risk and Mitigation Measures With a High-performance Cascade Impactor
30. Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine
31. Lung Deposition and Pharmacokinetics of Cyclosporine After Aerosolization in Lung Transplant Patients
32. A MULTIPROBE METHOD FOR MEASURING MUCOCILIARY CLEARANCE & ABSORPTION IN THE CF AIRWAY: S16.4
33. Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology
34. Droplet and Aerosol Generation With Endonasal Surgery: Methods to Mitigate Risk During the COVID‐19 Pandemic
35. AEROSOL-BASED METHODS OF ASSESSING MUCOCILIARY CLEARANCE: S3.2
36. Mucociliary Clearance as an Outcome Measure for Cystic Fibrosis Clinical Research
37. Inhaled Cyclosporine in Lung Transplantation
38. HLA-Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction
39. Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3
40. Droplet and Aerosol Generation With Mastoidectomy During the COVID-19 Pandemic: Assessment of Baseline Risk and Mitigation Measures With a High-performance Cascade Impactor.
41. Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect
42. Deposition studies of aerosol delivery by nasal cannula to infants
43. Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR
44. Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology.
45. Droplet and Aerosol Generation With Endonasal Surgery: Methods to Mitigate Risk During the COVID-19 Pandemic.
46. OPTICAL MEASUREMENT OF NEBULIZER SPRAYS: A QUANTITATIVE COMPARISON OF DIFFRACTION, PHASE DOPPLER INTERFEROMETRY, AND TIME OF FLIGHT TECHNIQUES
47. Surface Tension Gradient Driven Spreading on Aqueous Mucin Solutions: A Possible Route to Enhanced Pulmonary Drug Delivery
48. Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers
49. IN VITRO AND IN SILICO CHARACTERIZATION OF HUMAN NASAL EPITHELIAL ION AND LIQUID TRANSPORT MECHANISMS
50. ATP12A promotes mucus dysfunction during Type 2 airway inflammation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.